Nima Amini

Partner

Thank you for your interest. Before you communicate with one of our attorneys, please note: Any comments our attorneys share with you are general information and not legal advice. No attorney-client relationship will exist between you or your business and O’Melveny or any of its attorneys unless conflicts have been cleared, our management has given its approval, and an engagement letter has been signed. Meanwhile, you agree: we have no duty to advise you or provide you with legal assistance; you will not divulge any confidences or send any confidential or sensitive information to our attorneys (we are not in a position to keep it confidential and might be required to convey it to our clients); and, you may not use this contact to attempt to disqualify O’Melveny from representing other clients adverse to you or your business. By clicking "accept" you acknowledge receipt and agree to all of the terms of this paragraph and our Disclaimer.

pdf

Nima is a mergers and acquisitions specialist with more than a decade's experience advising multinationals, financial institutions, and investment funds on complex cross-border transactions across Asia, Europe, and the US in a variety of industries, including internet, technology, health care, media and entertainment, telecommunications, consumer retail, and education.

His practice primarily focuses on public and private company mergers, acquisitions, tender offers, asset purchases, PIPEs, divestitures, and joint venture transactions. He has also been continually active on Chinese outbound acquisitions into Europe and the US, as well as advising special committees, issuers, founders, private equity sponsors, and financial advisors in more than two dozen “going-private” transactions involving Asia-based companies listed in the US.

VIEW MORE

Admissions

Bar Admissions

  • Hong Kong
  • California
  • Minnesota
  • District of Columbia

Education

  • Columbia University, J.D.: Harlan Fiske Stone Scholar 
  • University of California at Berkeley, B.A.: magna cum laude 

“Going Private” or Conflict Transactions

  • WuXi PharmaTech (NYSE: WX), a leading R&D company serving the pharmaceutical, biotechnology, and medical device industries with operations in China and the US, in connection with its US$3.3 billion acquisition by a consortium comprised of Temasek, Ally Bridge Group, Boyu Capital, Hillhouse Capital, Ping An Insurance and certain WuXi senior executives 
  • Giant Interactive (NYSE: GA), one of China’s leading online game developers, in connection with its US$3.0 billion “going private” buy-out by affiliates of Baring Private Equity, Hony Capital, CDH Investments, and Giant’s chairman (named “Global Merger and Acquisition Deal of the Year” by The American Lawyer, “Deal of the Year” by each of China Business Law Journal, ASIAN-MENA Counsel Magazine, and China Law and Practice, and “Asia Private Equity Deal” of the Year by IFLR)
  • Mindray Medical International (NYSE: MR), a leading developer, manufacturer and marketer of medical devices worldwide, in connection with a proposed US$3.5 billion leveraged buyout by the company’s management
  • Homeinns Hotel Group (NASDAQ:HMIN), leading economy hotel chain in China, in connection with a preliminary non-binding proposal from a buyer group comprised of company management, BTG Hotels and Ctrip.com International (among others), to acquire all of the outstanding shares of Homeinns that are not owned by the buyer group in a “going private” transaction valued at approximately US$1.5 billion
  • Special Committee of Hanwha SolarOne (NASDAQ: HSOL) in connection with SolarOne’s acquisition of Hanwha Q CELLS in an all-stock transaction at an implied value of US$1.2 billion
  • Special Committee of ShangPharma Corporation (NYSE: SHP), a leading China-based pharmaceutical and biotechnology research and development outsourcing company, in connection with its US$173 million “going private” acquisition by its founders and affiliates of TPG 
  • Special Committee of Feihe International (NYSE: ADY), one of the leading producers and distributors of premium infant formula, milk powder, and soybean, rice, and walnut products in China, in connection with its “going private” acquisition by its Chairman and CEO and an affiliate of Morgan Stanley Private Equity Asia in a transaction valued at approximately US$148 million
  • iSoftStone Holdings (NYSE: ISS), a leading China-based IT services provider, in connection with its acquisition by its chairman / chief executive officer and various funds managed by China Everbright Investment Management Limited in a “going private” transaction valued at approximately US$332 million
  • Zhongpin (NASDAQ: HOGS), a leading meat and food processing company that specializes in pork and pork products, vegetables, and fruits in China, in its US$370 million “going private” acquisition by its founder 
  • 7 Days Group (NYSE: SVN), a leading economy hotel chain based in China, in connection with its “going private” merger involving a consortium comprised of the company's co-founders and co-chairmen of its board of directors and affiliates of Sequoia Capital and the Carlyle Group in a transaction valued at approximately US$688 million
  • China Real Estate Information Corporation (NASDAQ: CRIC), a leading provider of real estate information, consulting, and online services, in connection with its “going private” merger with E-House (China) Holdings Limited (NYSE: EJ), its parent company and a leading real estate services company in China, in a cash and stock transaction valued at over US$600 million
  • Special Committee of CNinsure (NASDAQ: CISG), a China-based insurance brokerage firm, in connection with a US$950 million “going private” proposal from its Chairman and TPG Capital (terminated)
  • Founder and controlling shareholder of Tiens Biotech Group (NYSE Amex: TBV), a China-based nutritional supplement manufacturer, in a “going private” transaction
  • Financial advisor to the Special Committee of Le Gaga Holdings Limited (NASDAQ: GAGA), a leading greenhouse vegetable producer in China, in connection with a management-led buyout (together with Sequoia Capital) in a transaction valued at approximately US$179 million
  • Financial advisor to the Special Committee of SYSWIN (NYSE: SYSW), a leading primary real estate service provider in China, in connection with its “going private” merger involving Syswin’s CEO in a transaction valued at approximately US$100 million
  • Financial advisor to the Special Committee of Chemspec International (NYSE: CPC), a leading China-based contract manufacturer of highly-engineered specialty chemicals, in connection with a “going private” transaction involving Chemspec’s Chairman and Primavera Capital
  • China Hydroelectric (NYSE: CHC), an owner, developer, and operator of small hydroelectric power projects in the People’s Republic of China, in connection with its acquisition by NewQuest Capital Partners in a transaction valued at approximately US$190 million
  • Acorn International (NYSE: ATV), the largest TV retailer in China, in connection with an unsolicited tender offer by Acorn’s co-founders

Cross-border Public and Private Mergers and Acquisitions

  • China Kanghui Holdings (NYSE: KH), a leading provider of orthopedic devices in China, in its US$816 million acquisition by Medtronic
  • Montage Technology Group (NASDAQ: MONT), a global fabless provider of analog and mixed-signal semiconductor solutions, in connection with its US$693 million acquisition by Shanghai Pudong Science and Technology, a Chinese state-owned enterprise
  • Global Education & Technology Group (NASDAQ: GEDU), a leading provider of educational courses and test preparation services in China, in connection with its US$294 million acquisition by Pearson (NYSE: PSO) (LON: PSON) 
  • Mindray Medical International (NYSE: MR) in various acquisitions, including its acquisition of ZONARE Medical Systems, an ultrasound technology leader in the high-end radiology segment headquartered in California, and in its acquisition of the patient monitoring business of Datascope (NASDAQ: DSCP) to create the third largest player in the global patient monitoring device industry
  • New Focus Auto Tech Holdings (HK: 360; TWSE 9106), a leading automobile after-sales service and parts distribution company based in Shanghai and dual-listed in Hong Kong and Taiwan, in connection with its takeover by private equity firm CDH Investments in a deal valued at approximately US$154 million 
  • 1Verge Holdings, the controlling shareholder of Youku Tudou Inc. (NYSE: YOKU), China’s leading Internet television company, in connection with Alibaba Group’s US$1.22 billion investment in Youku Tudou through the purchase of newly issued shares from Youku Tudou and secondary shares from 1Verge, and the related shareholder agreement between 1Verge and Alibaba
  • Xitogen Technologies, a company engaging in the development, manufacturing, and sales of new generation flow cytometers and other IVD instruments, in connection with its sale to Danaher Corporation (NYSE: DHR), a global Fortune 200 company
  • Shandong Weigao Group (HKSE: 8199), a Chinese medical device maker, in a US$221 million equity investment by Medtronic and the establishment of a Sino-foreign cooperative joint venture to jointly market products
  • ASC Fine Wines Holding, the leading wine importer and distributor in China, in connection with its sale to an affiliate of Suntory Holdings Limited, one of Asia's leading beverage companies
  • Lucky Pai, a China-based TV home-shopping network, in connection with its sale to Lotte

Private Equity Investments

  • GIC, the investment arm of the Government of Singapore’s sovereign wealth fund, in connection with its purchase, alongside affiliates of Bain Capital Partners LLC, of an equity stake in outsourcing company Genpact Ltd. (NYSE: G) from affiliates of General Atlantic LLC and Oak Hill Capital Partners LP for an aggregate purchase price of US$1 billion as well as its participation in both a US$700 million and subsequent US$1.26 billion round of investments in XPO Logistics, Inc. (NYSE: XPO), a North American provider of freight transportation services, together with PSP Investments and Ontario Teachers' Pension Plan 
  • Hillhouse Capital in connection with its joint venture with a leading US hospital and research foundation, to engage in the business of hospital and medical management services, education services, and other support services to healthcare institutions in China 
  • Consortium consisting of Sequoia Capital, CITIC Capital, and FountainVest Partners, in a management-led US$180 million investment in SINA Corporation (NASDAQ: SINA), China’s leading web portal
  • Consortium led by FountainVest Partners in connection with its investment in the retail division of LJ International (NASDAQ: JADE), a global wholesaler and branded retailer of jewelry
  • The Carlyle Group in connection with its US$25 million convertible debt and equity investment in China Recycling Energy Corp. (NASDAQ: CREG), a provider of energy-saving and recycling systems and services in China
  • Canada Pension Plan Investment Board in connection with its purchase, alongside affiliates of Baring Private Equity Asia, of a controlling interest in Hexaware Technologies (BSE: 532129, NSE: HEXT), an information technology and business process outsourcing service provider based in Mumbai, India, for roughly US$460 million (named “2014 M&A Deal of the Year” by India Business Law Journal)
  • Baring Private Equity Asia in connection with a management-led spin-off of China CBN Investment Holdings from Asian American Gas, Inc., a coal bed methane business based in China 
  • Temasek Holdings in connection with various investments, including its equity investment in Vancl Corporation, an online-only apparel brand and retailer in China
  • Mount Kellett Capital Management in connection with various investments in the oil, gas, and natural resources sectors in China and Indonesia 
  • IDGVC Partners, in a wide array of equity or convertible debt investments in China-based companies listed in the US 
  • China Development Bank International in connection with its equity investment, together with a consortium of other investors, in Alibaba Group Holding
  • CA Media, the Asian investment arm of The Chernin Group, in its various investments and divestments, including its investment in Endemol India, the producer of popular Indian reality television shows
  • A group of investors led by New Quest Capital Management in their successful cross-border proxy fight to control of the board of directors of China Hydroelectric Corporation (NYSE: CHC) by removing a majority of its existing directors and replacing them with directors nominated by the group

Private Equity Funds

  • Various institutional investors, pension funds, and sovereign wealth funds in their sponsorship of or anchor investment in various China or Pan-Asia focused investment funds, including funds managed by FountainVest, Baring Private Equity Asia, Hony Capital, CITIC PE, CDH Investments, Hopu, China Consumer Capital, and Fosun

VIEW MORE